Cross-reactivity between piperacillin–tazobactam and cefoperazone–sulbactam in drug-induced immune thrombocytopenia
Journal of International Medical Research · 2023-03 · 51 (3)
DOI: 10.1177/03000605231162434 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of International Medical Research, online erschienen am 26.03.2023. Verfasst von Xiaoyan He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Chongqing University Jiangjin Hospital, 725 Jiangzhou Avenue, Jiangjin District, Chongqing, 402260, China. Hauptthemen laut MEDLINE: Cefoperazone, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Beta-lactam antibiotics commonly cause immune thrombocytopenia. Cross-reactivity in patients with drug-induced immune thrombocytopenia has rarely been reported. In this study, we describe the case of a 79-year-old man who developed thrombocytopenia after receiving piperacillin–tazobactam for an acute exacerbation of chronic obstructive pulmonary disease, and he was successfully treated with meropenem and cefotiam. However, thrombocytopenia recurred after cefoperazone–sulbactam administration. This indicated that cross-reactivity of platelet-specific antibodies occurred between piperacillin–tazobactam and cefoperazone–sulbactam. However, the responsible drug structures remain unknown, requiring further investigation. Likewise, chemical structure similarities among beta-lactam antibiotics must be examined to determine the risk of immune thrombocytopenia in the clinical setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Chongqing University Jiangjin Hospital, 725 Jiangzhou Avenue, Jiangjin District, Chongqing, 402260, China.
- Department of Pharmacy, Central Hospital of Jiangjin District, Chongqing, 725 Jiangzhou Avenue, Jiangjin District, Chongqing, 402260, China.
- Department of Respiratory Medicine, Chongqing University Jiangjin Hospital, 725 Jiangzhou Avenue, Jiangjin District, Chongqing, China.
- Department of Respiratory Medicine, Central Hospital of Jiangjin District, Chongqing, 725 Jiangzhou Avenue, Jiangjin District, Chongqing, 402260, China.
ORCID-Profile: Ling Ding
Zitieren
APA
He, X., Huang, W., Wan, X., Li, X., Chang, Q., & Ding, L. (2023). Cross-reactivity between piperacillin–tazobactam and cefoperazone–sulbactam in drug-induced immune thrombocytopenia. Journal of International Medical Research, 51(3). https://doi.org/10.1177/03000605231162434
Vancouver
He X, Huang W, Wan X, Li X, Chang Q, Ding L. Cross-reactivity between piperacillin–tazobactam and cefoperazone–sulbactam in drug-induced immune thrombocytopenia. Journal of International Medical Research. 2023;51(3). doi:10.1177/03000605231162434
BibTeX
@article{He2023,
author = {He, Xiaoyan and Huang, Wanting and Wan, Xiong and Li, Xiaoya and Chang, Qiuhong and Ding, Ling},
title = {Cross-reactivity between piperacillin–tazobactam and cefoperazone–sulbactam in drug-induced immune thrombocytopenia},
journal = {Journal of International Medical Research},
year = {2023},
volume = {51},
number = {3},
doi = {10.1177/03000605231162434}
}
EUVIMED